IN2012DN02200A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02200A IN2012DN02200A IN2200DEN2012A IN2012DN02200A IN 2012DN02200 A IN2012DN02200 A IN 2012DN02200A IN 2200DEN2012 A IN2200DEN2012 A IN 2200DEN2012A IN 2012DN02200 A IN2012DN02200 A IN 2012DN02200A
- Authority
- IN
- India
- Prior art keywords
- vivo
- gcmaf
- macrophages
- nagalase
- contacting
- Prior art date
Links
- 210000002540 macrophage Anatomy 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 244000052616 bacterial pathogen Species 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 244000052613 viral pathogen Species 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Nanotechnology (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23608809P | 2009-08-22 | 2009-08-22 | |
| PCT/US2010/046356 WO2011028485A2 (en) | 2009-08-22 | 2010-08-23 | Tumoricidal, bactericidal, or viricidal macrophage activation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02200A true IN2012DN02200A (enExample) | 2015-08-21 |
Family
ID=43649882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2200DEN2012 IN2012DN02200A (enExample) | 2009-08-22 | 2010-08-23 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110123591A1 (enExample) |
| EP (1) | EP2467154A4 (enExample) |
| CN (1) | CN102596223A (enExample) |
| AU (1) | AU2010289901A1 (enExample) |
| CA (1) | CA2771900A1 (enExample) |
| IN (1) | IN2012DN02200A (enExample) |
| TW (1) | TW201113372A (enExample) |
| WO (1) | WO2011028485A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2694088B1 (en) * | 2011-04-07 | 2017-06-07 | Efranat Ltd. | Macrophage activating factor for pharmaceutical compositions |
| EP3563864A1 (en) * | 2013-01-18 | 2019-11-06 | Kline, Ellis | Selective glycosidase regimen for immune programming and treatment of cancer |
| CN111601606A (zh) * | 2017-11-29 | 2020-08-28 | 菲格内有限责任公司 | 用于活化的成纤维细胞与免疫细胞的相互作用及其用途 |
| US12485174B2 (en) | 2019-06-27 | 2025-12-02 | The George Washington University, A Congressionally Chartered Not-For-Profit Corporation | HDAC6-activated macrophages, compositions, and uses thereof |
| RU2717218C1 (ru) * | 2019-08-07 | 2020-03-18 | Зайцева Инга Николаевна | Способ торможения роста подкожного трансплантата экспериментальной глиобластомы человека u-87, перевитого иммунодефицитным мышам nu/j |
| CN114854579A (zh) * | 2022-04-13 | 2022-08-05 | 武汉大学 | 可用于临床的外周血特定亚群细胞外囊泡分离平台 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410269B1 (en) * | 1995-06-07 | 2002-06-25 | Nobuto Yamamoto | Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
| US20050103712A1 (en) * | 2003-11-13 | 2005-05-19 | Voyce Brian D. | Methods and devices for treating severe peripheral bacterial infections |
-
2010
- 2010-08-23 IN IN2200DEN2012 patent/IN2012DN02200A/en unknown
- 2010-08-23 US US12/861,575 patent/US20110123591A1/en not_active Abandoned
- 2010-08-23 WO PCT/US2010/046356 patent/WO2011028485A2/en not_active Ceased
- 2010-08-23 CA CA2771900A patent/CA2771900A1/en not_active Abandoned
- 2010-08-23 AU AU2010289901A patent/AU2010289901A1/en not_active Abandoned
- 2010-08-23 TW TW099128181A patent/TW201113372A/zh unknown
- 2010-08-23 CN CN2010800374048A patent/CN102596223A/zh active Pending
- 2010-08-23 EP EP10814210A patent/EP2467154A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| TW201113372A (en) | 2011-04-16 |
| EP2467154A2 (en) | 2012-06-27 |
| CN102596223A (zh) | 2012-07-18 |
| EP2467154A4 (en) | 2013-03-27 |
| WO2011028485A3 (en) | 2011-07-14 |
| CA2771900A1 (en) | 2011-03-10 |
| AU2010289901A1 (en) | 2012-03-15 |
| US20110123591A1 (en) | 2011-05-26 |
| WO2011028485A2 (en) | 2011-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02200A (enExample) | ||
| EP3208615A3 (en) | Uses of labeled hsp90 inhibitors | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| WO2014135987A3 (en) | Frequency optimization in ultrasound treatment | |
| EP4585168A3 (en) | A device for treatment of aneurysm | |
| WO2011127211A3 (en) | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders | |
| CL2010001021A1 (es) | Un metodo para operar un cabezal e terapia, de un sistema ultrasonico, para apoyar un tratamiento para contornear sitios corporales, y sistema ultrasonico para terapia cosmeticas. | |
| WO2010047923A3 (en) | Methods and systems for treating breast cancer using external beam radiation | |
| PH12013500187A1 (en) | Sirna targeting vegfa and methods for treatment in vivo | |
| MX2015001716A (es) | Niclosamida para el tratamiento de tumores solidos. | |
| MX2011010511A (es) | Regimen de tratamiento que utiliza neratinib para cancer de mama. | |
| SI2124640T1 (sl) | Glukoza izomeraza za uporabo v zdravljenju fruktozne intolerance | |
| WO2010141143A3 (en) | Engineered avirulent bacteria strains and use in medical treatments | |
| WO2013120795A3 (en) | Brachytherapy system & in vivo dose detector therefor | |
| WO2008095164A3 (en) | Biofeedback | |
| CN201939733U (zh) | 病原菌消杀器 | |
| CN202027947U (zh) | 病原菌消杀器 | |
| WO2011098060A3 (de) | Therapieoptimierung bei krebspatienten durch austesten von therapiekombinationen mittels in vitro testungen | |
| RU2010136626A (ru) | Способ усиления действия ультразвука при лечении гипертермией опухолевых тканей путем использования нанокластеров кремния | |
| UA54725U (ru) | Способ определения переносимости лекарственных средств при проведении первой фазы клинических исследований и исследовании биоэквивалентности | |
| Островський | Changes in the cells and tissues of living organisms under the influence of shock-wave therapy (literature review) | |
| UA49735U (ru) | Способ лечения больных гиперактивным мочевым пузырем с гиперкинетическим детрузором | |
| UA61552U (ru) | Способ лечения замедленной консолидации переломов и ложных суставов костей | |
| TR200804036U (tr) | Arter tespit ateli. | |
| UA79016U (ru) | Способ выбора показаний к оперативному лечению больных хроническим плевритом, совмещенным с легочными формами туберкулеза |